A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Biogen Inc. stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 2,052 shares of BIIB stock, worth $300,556. This represents 0.59% of its overall portfolio holdings.

Number of Shares
2,052
Holding current value
$300,556
% of portfolio
0.59%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$212.02 - $267.71 $435,065 - $549,340
2,052 New
2,052 $442,000
Q3 2023

Nov 06, 2023

SELL
$253.3 - $285.89 $397,427 - $448,561
-1,569 Reduced 59.23%
1,080 $277,000
Q2 2023

Aug 03, 2023

SELL
$275.25 - $318.06 $319,014 - $368,631
-1,159 Reduced 30.44%
2,649 $754,000
Q1 2023

May 02, 2023

BUY
$256.56 - $292.34 $5,644 - $6,431
22 Added 0.58%
3,808 $1.06 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $955,737 - $1.16 Million
3,786 New
3,786 $1.05 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cognios Beta Neutral Large Cap Fund, LP Portfolio

Follow Cognios Beta Neutral Large Cap Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.